NYSE$IQV

IQVIA Holdings Inc. · Q3 2022 earnings

Q3 2022 earnings · · Investor relations

Briefing

IQVIA reported strong operational and financial performance, with impressive organic revenue growth and strong free cash flow generation.

IQVIA's third-quarter 2022 results showcased strong financial performance. Revenue reached $3,562 million, a 5.0% increase year-over-year. GAAP Net Income grew by 8.4% to $283 million, with adjusted diluted earnings per share increasing by 14.3% to $2.48. The company's R&D Solutions also saw quarterly bookings exceeding $2.5 billion.

  • Revenue for the third quarter reached $3,562 million, representing a 5.0% increase compared to the previous year.
  • GAAP Net Income for the third quarter was $283 million, reflecting an 8.4% growth year-over-year.
  • Adjusted Diluted Earnings per Share increased by 14.3% year-over-year, reaching $2.48 for the third quarter.
  • R&D Solutions quarterly bookings exceeded $2.5 billion, with a book-to-bill ratio of 1.39x excluding reimbursed expenses.

Headline financials

Total Revenue

$3.56B

Previous: $3.39B+5.0%
EPS (adj)

$2.48

Previous: $2.17+14.3%
R&D Solutions contracted backlog

$25.8B

Previous: $24.4B+5.7%
Free Cash Flow

$283M

Previous: $261M+8.4%
Net Income

$283M

Previous: $261M+8.4%
Operating Income

$472M

Previous: $302M+56.3%
Gross Profit

$812M

Previous: $727M+11.7%
Cash & Equivalents

$1.27B

Previous: $1.47B-13.3%
Total Assets

$24.2B

Previous: $24B+0.8%
Stock-Based Comp

$61M

Previous: $48M+27.1%

Revenue & EPS history

IQVIA · Revenue · Quarterly

$3.56B

Q3 2022+5%vs Q3 2021
Beat estimate in 12 of 15 quarters(80%)
ActualEstimate

Revenue by segment

IQVIA · $3.56B total across 3 segments · Q3 2022

  • Research & Development Solutions
    $1.98B+6.8%
  • Technology & Analytics Solutions
    $1.4B+4.7%
  • Contract Sales & Medical Solutions
    $183M-9.0%

Forward guidance

For the fourth quarter of 2022, the company expects revenue to be between $3,654 million and $3,754 million, representing growth of 5.5 to 8.2 percent at constant currency and 0.5 to 3.2 percent on a reported basis. Adjusted Diluted Earnings per Share to be between $2.72 and $2.82, representing growth of 6.7 to 10.6 percent on a reported basis.

Tailwinds

  • Revenue to be between $3,654 million and $3,754 million, representing growth of 5.5 to 8.2 percent at constant currency
  • Underlying constant currency organic growth excluding COVID-related work of over 10 percent at the midpoint.
  • Adjusted EBITDA to be between $904 million and $934 million
  • Adjusted Diluted Earnings per Share to be between $2.72 and $2.82
  • Adjusted Diluted Earnings per Share representing growth of 6.7 to 10.6 percent on a reported basis

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2022

Historical avgQ3 2022

+1.4%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+1.9%

Avg return

30 days after

65%

37 / 57 earnings

Positive

+12.5%

Q2 2018

Best reaction

-10.7%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+7.7%+10.9%+13.9%
Q4 2025-10.7%-9.9%-13.8%
Q3 2025+0.3%-0.4%+6.6%
Q2 2025-0.4%+1.1%-1.6%
Q1 2025-4.0%-2.2%-3.2%
Q4 2024+2.2%-2.2%-6.7%
Q3 2024-3.2%-1.5%-7.0%
Q2 2024+6.3%+6.7%+10.0%
Q1 2024-4.1%-1.6%-5.9%
Q4 2023+12.2%+10.8%+17.4%
Q3 2023+5.3%+9.7%+20.0%
Q2 2023-2.1%-3.1%-0.5%
Q1 2023-0.9%-2.3%+5.0%
Q4 2022+0.8%-1.4%-14.4%
Q3 2022+1.4%+6.1%+11.3%
Q2 2022+0.5%-0.4%+8.3%
Q1 2022+6.1%+5.0%+6.7%
Q4 2021-3.2%-4.8%-6.9%
Q3 2021+2.1%+1.8%+6.6%
Q2 2021-0.8%+0.2%+4.5%
Q1 2021+6.1%+7.0%+9.1%
Q4 2020+4.9%+4.8%+1.6%
Q3 2020+3.2%+2.1%+3.4%
Q2 2020+2.9%+3.4%+0.4%
Q1 2020+8.5%+3.5%+10.9%
Q4 2019+2.5%+1.6%-26.6%
Q3 2019-3.8%-2.4%-2.7%
Q2 2019+2.1%+1.6%-2.3%
Q1 2019-2.0%-0.1%-2.2%
Q4 2018+7.6%+7.3%+7.4%
Q3 2018-3.5%-5.3%-8.4%
Q2 2018+12.5%+8.2%+11.7%
Q1 2018-0.7%+0.2%+2.6%
Q4 2017+1.5%+1.7%+5.6%
Q3 2017+6.1%+6.5%+2.7%
Q2 2017-1.3%-1.0%+4.4%
Q1 2017-3.7%-2.0%+3.0%
Q4 2016-2.7%-4.1%+0.5%
Q3 2016+0.8%+4.1%+3.3%
Q2 2016+3.3%+4.2%+0.3%
Q1 2016-5.9%
Q4 2015+3.6%
Q3 2015-6.2%
Q2 2015+2.6%
Q1 2015-4.9%
Q4 2014+4.3%
Q3 2014+0.9%
Q2 2014-3.1%
Q1 2014+0.4%
Q4 2011+7.5%
Q4 2013+7.5%
Q3 2012+0.1%
Q3 2013+0.1%
Q2 2012+0.8%
Q2 2013+0.8%
Q1 2012+5.0%
Q4 2012+5.0%
Q1 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro